Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November

Size: px
Start display at page:

Download "Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November 2008 www.cumbria.nhs.uk"

Transcription

1 Cancer in Cumbria Jennifer Clay Public Health Intelligence Analyst November

2 2

3 Table of contents: Summary... 4 Introduction..6 Cancer Incidence 7 Cancer Mortality Cancer Survival 22 Appendices Appendix 1 26 Appendix Appendix 3 30 Appendix 4 32 Appendix

4 Summary On average each year in Cumbria: 2,600 people are diagnosed with cancer 1,500 people die from cancer 6,000 people are living with cancer Projected annual increase of 500 registrations (incidence) in population aged 65 and over by 2015 increasing by a further 900 by 2031 Cumbria has statistically significantly higher levels of: Cancer mortality: Stomach cancer Colo-rectal cancer Prostate cancer Bladder cancer (men) Brain cancer (women) Is the second major cause of death after coronary heart diseases Causes one in four deaths Lung cancer is the major cause of cancer deaths accounting for almost one in four deaths from cancer Projected 10% growth in male deaths from cancer by 2017 One third of all cancer deaths are to someone aged below 75 years 160 premature deaths will be averted should Cumbria achieve its Saving Lives target Premature cancer mortality is statistically significantly higher in the most deprived parts of Cumbria Annually cancer accounts for 8,000 years of lost life the equivalent of 106 people On average 11 years of life are lost to cancer Cumbria has statistically higher levels of mortality from: Cancer in men Colo-rectal cancer Mesothelioma (men) Testis Ovary Cancer survival in Cumbria: 38% of men are alive 5 years after diagnosis 51% of women are alive 5 years after diagnosis Over 80% of women are alive 5 years after being diagnosed with breast cancer 4

5 Nationally pancreatic cancer has the worst survival rate at 3% Nationally testicular cancer has the highest survival rate at 97% People living in the most deprived areas are less likely to survive cancer There is a 53.3% cancer survival rate for the more affluent parts of Cumbria Cancer survival in the most deprived areas of Cumbria is 39.2% 5

6 Cancer in Cumbria Introduction On average each year in Cumbria: 2,600 people are diagnosed with cancer 1,500 people die from cancer An individual s risk of developing cancer depends on many factors, including age, lifestyle and genetic make-up. It is estimated that up to half of all cancers cases diagnosed in the UK could be avoided if people made changes to their lifestyles, such as stopping smoking, moderate alcohol intake, maintaining a health bodyweight and avoiding excessive sun exposure. More than a quarter of all deaths from cancer (including almost 90% of lung cancer deaths) are linked to tobacco smoking. Estimates suggest that, in the UK, up to 13,000 cases of cancer could be avoided if no-one exceeded a body mass index (BMI) of 25. Research suggests that each of the following increase the risk of certain cancers: alcohol consumption, a low fibre diet, low consumption of fruit and vegetables, high consumption of red and processed meats and higher intake of salt or saturated fats. Excessive exposure to UV radiation (from the sun or sun beds) is the most important modifiable risk factor for skin cancers. A small number of infectious agents, especially certain viruses, play a key role in causing certain types of cancer. It is estimated that inherited factors cause up to 10% of all cancers. Factors such as the age at which a woman has her first child and number of children, affect the risk of the most common female cancers (Cancer Research UK). This is the second report examining cancer within Cumbria. The data used has been collated from several sources including: the Office for National Statistics, North West Cancer Registry, National Cancer e-atlas and Cancer Research UK. Cancer incidence (new cases), mortality and survival will be detailed, with particular emphasis being placed on those cancer sites targeted within World Class Commissioning where better detection and treatment will impact on premature mortality from: lung, breast and colo-rectal cancer. There are over two hundred different types of cancer. These can be malignant or benign. This report will be looking at those cancers classed as malignant and will be referred to as cancer(s) or malignant neoplasm(s) (MN). Cancers are coded using the International Classification of Diseases (ICD10) system with malignant neoplasms falling within the range C00 to C97. Due to the under reporting nationally of non-melanoma skin cancer (C44), this grouping has been excluded from the incidence analysis. Cancer Incidence 6

7 Overall it is estimated that more than one in three people will develop some form of cancer during their lifetime. This compares to an estimated risk of 1 in 27 for people aged up to 50 years. Estimates of the life time risk of developing some of the most common cancers are shown in table 1. These estimates assume no change in the current incidence rates and should be used as an approximate guide only. Table 1: Risk of being diagnosed with cancer by age 65and over a lifetime, England & Wales 1997 % of cohort that develop cancer Males Females by age 65 over lifetime lifetime risk by age 65 over lifetime lifetime risk Bladder in in 79 Brain and CNS in in 207 Breast in 9 Cervix in 116 Kidney in in 162 Large bowel in in 20 Leukaemia in in 127 Lung in in 23 Melanoma in in 117 Multiple myeloma in in 204 Non-Hodgkin lymphoma in in 83 Oesophagus in in 95 Ovary in 48 Pancreas in in 95 Prostate in 14 Stomach in in 86 Uterus in 73 Source: Cancer Research UK Cancer occurs predominantly in older people as shown by the differences between the above cohorts. For example a woman s risk of developing breast cancer by age 65 is less than 6% but the overall lifetime risk is 11%. For men there is a less than 2% risk of developing lung cancer by age 65; this increases to 8% over a lifetime. Bearing in mind that life expectancy is increasing with more elderly people alive today than ever before Cumbria can expect to see an increase in the number of cancers diagnosed each year as a result of the aging population. Cancer data are collected by nine independent regional registries in England. Due to the pattern of patient referral within Cumbria the Primary Care Trust deals two registries. These are: the Northern and Yorkshire Registry, collecting details of patients residing in the north of the county, whilst the North Western Registry deals with those patients in the south of Cumbria. Registry data are dynamic the files are always open and records may be amended when more accurate data becomes available. Consequently figures can change over time so there may well be small discrepancies especially when comparing data from earlier reports. The timeliness of 7

8 Registry data are affected by the many checks carried out on an individual record, therefore the latest data available are for The Northern and Yorkshire Registry share data for North Cumbria with their colleagues in the North Western Registry enabling them to present data for the North West Region in its entirety. Figure 1: Cumbria cancer incidence trend Registraitions (number) Figure I shows the cancer incidence trend for Cumbria. Over the ten year period there has been a 17% increase in the number of reported cases rising from 2,354 cases in 1996 to 2,755 for Average annual age specific incidence rates for Cumbria are shown for the period, 2003 to 2005 in figure 2. This clearly illustrates the association of cancer with an older population. Men aged 65 and over account for 70% of all new registrations. This gives a crude rate of 2,205.3 per 100,000 males aged 65 plus whereas their younger counterparts aged below 65 years have a rate of per 100,000. Figure 2: Cumbria, average annual age specific cancer incidence rate, Women aged over 65 years 4,000 Males account for 60% of all new 3,500 Females registrations. This gives a 3,000 crude rate of 1,516.3 per 2, ,000 females aged 65 and 2,000 over. This compares with a 1,500 rate of per 100,000 1,000 women for the younger cohort. 500 The national cervical and 0 breast screening programmes have lead to the earlier Age group detection of these cancers and account for the higher incidence rate in the younger female population. Screening coverage as at 31 st March 2007 reveals that 82% of women in Cumbria aged between 25 and 64 years have been checked for cervical cancer, this compares to 79% nationally. Figures for breast cancer show that 79% of women locally aged between 53 and 64 years have been screened, this is above the national average of 76%. Age specific incidence rate/100, Number (000's) Cumbria Population projections: persons aged 65 and over (2006 based) Figure 3: Cumbria population (65+) projection The projected increase in the elderly population must be of concern to those planning services for the future. Figure 3 illustrates the projected growth in the Cumbria population aged over 65 8

9 years. This is not an exact science but projections suggest that by 2031 the older population in Cumbria will have grown by some 74%. Even just looking ahead to 2016 there may well be a growth of 28% for this cohort. Looking again to the future, projecting what will happen with regards to the number of new cancer cases is difficult. Applying current rates (based on 1,811 registrations) to the projected growth in the population aged 65 plus suggests an additional 500 cases by 2015, increasing by a further 900 registrations by 2031 as illustrated in figure 4. Figure 4: Projected growth in cancer registrations, population aged 65 and over Number 3,300 3,100 2,900 2,700 2,500 2,300 2,100 1,900 1,700 1, Moving on from the incidence of cancer, figure 6 examines the prevalence (new and existing cases) of cancer in the community. The introduction of the Quality and Outcomes Framework (QOF) gives for the first time the number of people living with a specific condition. Unfortunately QOF data are not available for specific age groups so figure 5 shows the projected prevalence for the total population. Latest figures for 2007/08 show that 1.2% of the population of Cumbria were living with a cancer. Applying this rate to the projected populations shows a 13% increase on current numbers by Figure 5: Projected cancer prevalence, total population Number 6,800 6,700 6,600 6,500 6,400 6,300 6,200 6,100 6,000 5,900 5,800 5, Projected cancer prevalence in Cumbria population (based on 2007/08 QOF rate of 1.2%) 6,722 The data used in figure 5 can be found in appendix Table 2 shows the standardised registration ratios (SRRs) for Cumbria for the period 2001 to These allow local incidence to be compared with the average rate for England (normally 100). A statistical calculation (confidence interval) is applied to 9

10 the resulting SRR which indicates if the figure is higher or lower than would be expected. Those sites that are statistically significantly higher or lower when compared to England are indicated by the use of sad (bad) or happy (good) faces. The table shows that cancer registrations for women are significantly higher: this can be interpreted as women in Cumbria having a statistically significant higher incidence rate for all cancers which is 3% greater than expected. On the other hand men in Cumbria have a significantly lower rate: this would be interpreted as a statistically significant lower rate which is 4% lower than expected. Table 2: Cumbria Standardised Registration Ratios, Cumbria Males Females Site ICD10 Registrations SRR Registrations SRR All cancers ex nmsc C00-C97xC MN Oesophagus C MN Stomach C MN Colon/Rectum C18-C MN Pancreas C MN Trachea, Bronchus, Lung C33-C Mal Melanoma Skin C Mesothelioma C MN Female Breast C MN Cervix Uteri C MN Uterus C MN Ovary C MN Prostate C MN Testis C MN Kidney ex Renal Pelvis C MN Bladder C Brain C Non-Hodgkin's Lymphoma C82-C Leukaemia C91-C Note: 1. Significant at p<0.05. This means we can be 95% certain that the particular SRR is higher or lower than the national level. 2. ".." denotes that data have been suppressed where the number of events is less than 5 or where subtraction from total may be disclosive. Source: Calculated in-house by Performance & Intelligence Section Cumbria has significantly higher incidence of: Stomach cancer Colo-rectal cancer Prostate cancer Bladder cancer (men) Brain cancer (women) Looking towards the district councils that constitute Cumbria table 3 shows those cancers that are significantly higher or lower. A more detailed breakdown of the data can be found in appendix 2. The National Cancer-Atlas can be found at: 10

11 this resource can be used to obtain trend data for local authorities and uses directly standardised rates (DSRs) to compare areas. The use of DSRs allows comparisons to be made between different populations. Direct standardisation takes account of age differences between different populations. Table 3: Statistically significant SRRs, Barrow Allerdale in Furness Carlisle Copeland Eden South Lakeland Significantly higher M F M F M F M F M F M F All cancers Stomach Colo-rectal Mesothelioma Uterus Ovary Prostate Kidney Significantly lower All cancers Lung Mal Melanoma Skin Cervix Kidney Leukaemia Figure 6: Projected increase in cancer incidence by 2015 Earlier the report looked at the All cancers projected number of new cancer Cumbria 31% registrations in the older South Lakeland 41% population. Figure 6 shows the projection for all cancers in the Eden 49% population. Again caution should Copeland 46% be used when quoting these Carlisle 9% figures as they are merely a projection of current numbers. By Barrow in Furness 32% 2015 Cumbria may see a 31% Allerdale 24% increase in the number of 0% 10% 20% 30% 40% 50% registrations. The spread of these is not equally divided across the county. Eden may well see a 50% increase in the number of cases. Currently Eden does have a greater proportion of older residents. At the other end Carlisle is projected to have the lowest increase at 9%. For those cancers featured in the World Class Commissioning document figures 7 and 8 show the projections for colo-rectal cancer and female breast cancer. With the exception of Allerdale projections for lung cancer show a decline in the number of registrations and are not shown here. 11

12 Increases are projected for both cancers with Barrow in Furness carrying the highest increase for colo-rectal cancer with an anticipated growth of 64%. Breast cancer shows the most startling increase probably due to the breast screening programme with a 76% increase overall, Copeland is projected to have a massive increase of 162%. Figure 7: Projected increase in colo-rectal cancer by 2015 Colo-rectal cancer Cumbria 33% South Lakeland 4% Eden Copeland 50% 52% Carlisle 26% Barrow in Furness 64% Allerdale 36% -3% 17% 37% 57% 77% Figure 8: Projected increase in breast cancer by 2015 Female breast cancer Cumbria South Lakeland Eden 53% 76% 84% Copeland 162% Carlisle Barrow in Furness Allerdale 71% 76% 71% The figures the projections are based on can be found in appendix 3. 12

13 Cancer Mortality Cancer is the second major cause of death accounting for 26% of all deaths locally; 1,462 people were registered as dying from cancer in This is just below the national average of 27% of all deaths. Figure 9 illustrates the top 5 cancer sites within Cumbria accounting for over half of all cancer deaths. Lung cancer is responsible for the greatest proportion of cancer deaths with one in four men and one in five women dying from the disease. In the female population breast cancer is the second major cause of death from cancer and is responsible for almost one fifth of deaths in this group. For men colo-rectal cancer is the next major cause of death and is responsible for 12% of male cancer deaths. Figure 9: Cumbria - major cancer sites Males Females 44% 5% 7% 8% 25% 12% Lung Colo-rectal Prostate Oesophagus Pancreas Other sites 44% 3% 5% 8% 21% 18% Lung Breast Colo-rectal Pancreas Oesophagus Other sites The cancer mortality trend is show in figure 10. Slightly more men die from cancer compared to women. Looking ahead projections suggest a 10% increase in the number of male deaths by 2017 with a small increase of 1% for women. Figure 10: Cumbria cancer mortality trend Cumbria : Cancer mortality trend Death (number) Male Female Figure 11 compares the cancer incidence and mortality rate trend. A person diagnosed with cancer may not necessarily die from cancer, if they do, it may not be 13

14 Figure 11: cancer trends crude rate, persons rate per 100, Cumbria: comparison between cancer incidence and mortality % 80% 60% 40% 20% 0% % 2006 Incidence Deaths : Cancer deaths by age group - as a percentage of all deaths 14% 24% 36% in the same year of diagnosis. The table shows that more people are diagnosed each year with some form of cancer than die from a cancer. On average each year there are 1,000 more cancer registrations than deaths. When looking at age at death, in Cumbria on average one third of all deaths are to people aged below 75 years of age. Of these cancer is responsible for two fifths as shown in figure 12. Cancer deaths are more or less equally split 50/50 when looking at deaths below/above 75 years. The Government set a target through Saving Lives, Our Healthier Nation to reduce the number of deaths from cancer for persons aged under 75 years by 20%. Figure 12: Cumbria - age at death Table 4 shows baseline data, progress to date and target rates for reducing premature mortality from cancer. The table is supported by graphs shown in figure 13 displaying the yearly directly standardised mortality rate. If current trends continue all districts within Cumbria will achieve their target Cancer death Other cause 48% 42% 27% 14% 27% 41% < All Age group ages rate and 160 lives will have been saved. Eden has already exceeded its target rate of 106 deaths per 100,000 people. Table 4: Saving Lives, Our Healthier Nation Target Baseline Progress Target 1995/ Area DSR Average Annual Deaths Number DSR Average Annual Deaths Number DSR Average Annual Deaths Number Cumbria Allerdale Barrow-in-Furness Carlisle Copeland Eden South Lakeland <75 14

15 Figure 13: Premature mortality trend for cancer DSR/100,000 DSR/100,000 DSR/100,000 DSR/100,000 DSR/100,000 DSR/100,000 DSR/100, Eng & Wales Cumbria Target Eng & Wales Cumbria Allerdale Target Cumbria Allerdale Barrow in Furness Eng & Wales Cumbria Barrow-in-Furness Target Eng & Wales Cumbria Carlisle Target Eng & Wales Cumbria Copeland Target Eng & Wales Cumbria Eden Target Eng & Wales Cumbria South Lakeland Target Carlisle Copeland Eden South Lakeland

16 To give some idea of cause of death table 14 shows premature mortality from cancer by broad ICD10 headings. More detailed discussion re individual sites will be discussed later within the report. Figure 14: Cancer mortality by chapter heading, Cumbria % 90% 80% 70% 60% 50% 40% 30% 20% 10% 0% < Digestive Respiratory Unspecified Lymphoid & blood Breast Male genital Urinary Female genital Brain Mesothelial Skin Mouth and throat Independent Thyroid/endocrine Bone All cancers Deprivation and lifestyle contributes to the risk of developing cancer when looking at health inequalities across Cumbria. Figure 15 shows the directly standardised premature mortality rate for selected cancers by deprivation quintile (IMD 2007) within Cumbria. Figure 15: Health inequalities and premature mortality selected cancer sites DSR/100, All cause premature mortality Quintile DSR/100, Colo-rectal cancer, premature mortality Quintile DSR/100, Lung cancer, premature mortality DSR/100, Female breast cancer, premature mortality Quintile Quintile When compared to the Cumbria average those people living in the worst deprivation (quintiles one and two) have a statistically significantly higher mortality rate from cancer when compared to their more affluent neighbours who have a significantly 16

17 lower rate. The same pattern is echoed in the lung cancer chart. Undoubtedly this re-enforces the link between smoking and those living in the poorer areas. Deaths from colo-rectal cancer and female breast cancer are significantly higher in quintile 1. Another way of looking at premature mortality is to examine the number of years of lost life (YLL). Table 5 examines the number of years by chapter heading. Cancer is responsible for one third of all deaths when looking at mortality in this manner. For the period 2005 to 2007 there were 2,186 cancer deaths in people aged below 75 years of age. In this cohort each person looses an average of 11 years of life. Converting the 24,000 years to actual people would result in 320 lives. These figures are broken down by localities in figure 6. Of the districts Carlisle fares worst with the greatest number of deaths and highest average years of lost life. Table 5: Cumbria premature mortality Chapter YLL Equates to (people) Malignant neoplasm 24,032 34% 320 Diseases of the circulatory system 15,190 22% 203 External cause 12,510 18% 167 Diseases of the digestive system 5,166 7% 69 Diseases of the respiratory system 4,008 6% 53 Diseases of the nervous system 2,844 4% 38 Other causes 6,588 9% 88 Total 70, Table 6: Premature mortality from cancer Area Deaths YLL Average YLL Equates to (people) Allerdale 453 5, Barrow in Furness 337 3, Carlisle 469 5, Copeland 333 3, Eden 187 1, South Lakeland 407 4, Cumbria 2,186 24, In terms of individual cancer sites figures 16 and 17 show the years of lost life for males and females. Here the total numbers of years of lost life for the period 2005 to 2007 are divided by the total number of deaths, resulting in an average number of years of lost life for every death. 17

18 Figure 16: Cumbria average number of YLL, males Premature mortality from cancer : Males MN Testis MM Skin MN Brain Non-Hodgkin's Lymphoma Other cancer MN Kidney ex Renal Pelvis Leukaemia MN Oesophagus All cancers MN Trachea, Bronchus & Lung MN Stomach MN Colon/Rectum Pancreas Mesothelioma MN Bladder MN Prostate Average number of years of lost life Although the number of deaths from testicular cancer is low (less than five) those deaths have resulted in the maximum loss of life - average of 18 years. Figure 17: Cumbria average number of YLL, females Premature mortality from cancer : Females 2005/2007 MN Cervix Uteri MM Skin MN Brain MN Female Breast Leukaemia All cancers MN Ovary Non-Hodgkin's Lymphoma MN Colon/Rectum MN Oesophagus Other cancer MN Kidney ex Renal Pelvis MN Trachea, Bronchus & Lung Mesothelioma Pancreas MN Stomach MN Uterus MN Bladder Average number of years of lost life Cervical cancer is responsible for the maximum loss of life in women - average of 23 years. In both instances this can be interpreted as the cancer developing in a 18

19 younger person, resulting in an increase in the number of years of lost life or in other words - dying younger. Ironically both diseases are treatable and curable. This should serve as a reminder for men of the importance of self examination and, for women to attend their cervical screening examination. In second place another preventable and treatable disease: malignant melanoma of the skin in both men and women, results in an average of 18 years of lost life for each death. Grouping together total number of years of lost life from cancer, reveals that lung cancer accounts for some 23% of the total in men, whilst breast cancer at 24% is the major cause of lost life in women. Listed below are those sites with the greatest number of years of lost life: Lung cancer : 4,854 years Female breast cancer : 2,899 years Colo-rectal cancer : 2,226 years Oesophageal cancer : 1,159 years Brain cancer : 1,129 years Ovarian cancer : 958 years Pancreatic cancer : 941 years Other sites : 9,867 years Moving on from this topic a more in depth analysis of cancer mortality was undertaken. Similar to standardised registration ratios, standardised mortality ratios (SMRS) have been calculated. Table 7 shows the rates for Cumbria by sex; those sites that are statistically significantly higher or lower when compared to England and Wales are again indicated by the use of sad or happy faces. At the time these rates were calculated detailed national data for 2007 were not available. Cumbria has significantly higher mortality rates for: All ages All causes (men) Colo-rectal cancer Mesothelioma (men) Testis Ovary Under 75 years Mesothelioma (men) Colo-rectal cancer (women) 19

20 Table 7: Cumbria Standardised Mortality Ratios, Males All ages Under 75 years Site ICD No. Deaths SMR Deaths SMR All cancers C00-C97 2, , MN Oesophagus C MN Stomach C MN Colon/Rectum C18-C MN Pancreas C MN Trachea, Bronchus, Lung C33-C Mal Melanoma Skin C Mesothelioma C MN Prostate C MN Testis C MN Kidney ex Renal Pelvis C MN Bladder C MN Brain C Non-Hodgkin's Lymphoma C82-C Leukaemia C91-C Females All cancers C00-C97 2, , MN Oesophagus C MN Stomach C MN Colon/Rectum C18-C MN Pancreas C MN Trachea, Bronchus, Lung C33-C Mal Melanoma Skin C Mesothelioma C MN Female Breast C MN Cervix Uteri C MN Uterus C MN Ovary C MN Kidney ex Renal Pelvis C MN Bladder C MN Brain C Non-Hodgkin's Lymphoma C82-C Leukaemia C91-C Note: 1. Significant at p<0.05. This means we can be 95% certain that the particular SRR is higher or lower than the national level. Source: Calculated in-house by Performance & Intelligence Section Statistically significant SMRs for district councils are found in table 8. A more detailed breakdown of the data can be found in appendices 4 and 5. 20

21 Table 8: Statistically significant SMRS, Barrow Allerdale in Furness Carlisle Copeland Eden South Lakeland All ages M F M F M F M F M F M F Significantly higher All cancers Stomach Colon/Rectum Trachea, Bronchus, Lung Mesothelioma Cervix Uteri Prostate Testis Kidney ex Renal Pelvis Significantly lower All cancers Pancreas Trachea, Bronchus, Lung Leukaemia Under 75 years Significantly higher All cancers Oesophagus Stomach Colon/Rectum Pancreas Trachea, Bronchus, Lung Mesothelioma Testis Significantly lower All cancers Trachea, Bronchus, Lung Bladder

Cancer in Ireland 2013: Annual report of the National Cancer Registry

Cancer in Ireland 2013: Annual report of the National Cancer Registry Cancer in 2013: Annual report of the National Cancer Registry ABBREVIATIONS Acronyms 95% CI 95% confidence interval APC Annual percentage change ASR Age standardised rate (European standard population)

More information

Number. Source: Vital Records, M CDPH

Number. Source: Vital Records, M CDPH Epidemiology of Cancer in Department of Public Health Revised April 212 Introduction The general public is very concerned about cancer in the community. Many residents believe that cancer rates are high

More information

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales

The effect of the introduction of ICD-10 on cancer mortality trends in England and Wales The effect of the introduction of ICD-10 on cancer mortality trends in Anita Brock, Clare Griffiths and Cleo Rooney, Offi ce for INTRODUCTION From January 2001 deaths in have been coded to the Tenth Revision

More information

Cancer in Wales. People living longer increases the number of new cancer cases

Cancer in Wales. People living longer increases the number of new cancer cases Welsh Cancer Intelligence and Surveillance Unit, Health Intelligence Division, Public Health Wales Iechyd Cyhoeddus Cymru Public Health Wales Am y fersiwn Gymraeg ewch i Cancer in Wales A summary report

More information

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations

Table 2.2. Cohort studies of consumption of alcoholic beverages and cancer in special populations North America Canada Canadian 1951 Schmidt & Popham (1981) 1951 70 9 889 alcoholic men, aged 15 years, admitted to the clinical service of the Addiction Research Foundation of Ontario between Death records

More information

Statistics fact sheet

Statistics fact sheet Statistics fact sheet Fact sheet last updated January 2015 EXTERNAL VERSION Macmillan Cancer Support Page 1 of 10 Macmillan and statistics Statistics are important to Macmillan because they help us represent

More information

Cancer Survival - How Long Do People Survive?

Cancer Survival - How Long Do People Survive? A research briefing paper by Macmillan Cancer Support Introduction Key findings 3 People with cancer are surviving longer 4 Median survival time has seen dramatic improvement for some cancers 5 Median

More information

Section 8» Incidence, Mortality, Survival and Prevalence

Section 8» Incidence, Mortality, Survival and Prevalence Section 8» Incidence, Mortality, Survival and Prevalence 8.1. Description of Statistics Reported This section focuses on the regional distribution of cancer with data derived from the BC Cancer Registry

More information

Chapter I Overview Chapter Contents

Chapter I Overview Chapter Contents Chapter I Overview Chapter Contents Table Number Contents I-1 Estimated New Cancer Cases and Deaths for 2005 I-2 53-Year Trends in US Cancer Death Rates I-3 Summary of Changes in Cancer Incidence and Mortality

More information

Gateshead Joint Strategic Needs Assessment 2012 Data Annex Chapter 6: Cancer

Gateshead Joint Strategic Needs Assessment 2012 Data Annex Chapter 6: Cancer Gateshead Joint Strategic Needs Assessment 2012 Data Annex Chapter 6: Cancer Gateshead Joint Strategic Needs Assessment 2012 Data Annex Chapter 6 Cancer This Annex to the Gateshead Joint Strategic Needs

More information

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013. National Registry of Diseases Office (NRDO)

Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013. National Registry of Diseases Office (NRDO) Singapore Cancer Registry Annual Registry Report Trends in Cancer Incidence in Singapore 2009 2013 National Registry of Diseases Office (NRDO) Released November 3, 2014 Acknowledgement This report was

More information

CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer

CANCER EXPLAINED. Union for International Cancer Control Union Internationale Contre le Cancer MEDIA FACTSHEET CANCER EXPLAINED What is cancer? Cancer is a disease which occurs when changes in a group of normal cells within the body lead to uncontrolled growth causing a lump called a tumour; this

More information

Cancer Incidence and Survival By Major Ethnic Group, England, 2002-2006

Cancer Incidence and Survival By Major Ethnic Group, England, 2002-2006 national cancer intelligence network Cancer Incidence and Survival By Major Ethnic Group, England, 00-006 info.cancerresearchuk.org/cancerstats www.ncin.org.uk Cancer Incidence and Survival By Major Ethnic

More information

Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research. Survival ratios of cancer patients by area in Finland

Finnish Cancer Registry Institute for Statistical and Epidemiological Cancer Research. Survival ratios of cancer patients by area in Finland Survival ratios of cancer patients by area in Finland Pages 2 14 present the relative survival ratios for patients diagnosed in 2005 2012 and followed-up in 2010 2012 (see Methods p. 15) on different university

More information

AUSTRALIAN VIETNAM VETERANS Mortality and Cancer Incidence Studies. Overarching Executive Summary

AUSTRALIAN VIETNAM VETERANS Mortality and Cancer Incidence Studies. Overarching Executive Summary AUSTRALIAN VIETNAM VETERANS Mortality and Cancer Incidence Studies Overarching Executive Summary Study Study A u s t ra l i a n N a t i o n a l S e r v i c e V i e t n a m Ve t e ra n s : M o r t a l i

More information

Chapter 2: Health in Wales and the United Kingdom

Chapter 2: Health in Wales and the United Kingdom Chapter 2: Health in Wales and the United Kingdom This section uses statistics from a range of sources to compare health outcomes in Wales with the remainder of the United Kingdom. Population trends Annual

More information

Health. Social Trends 41. David Sweet. Edition No: Social Trends 41 Editor: Jen Beaumont. Office for National Statistics

Health. Social Trends 41. David Sweet. Edition No: Social Trends 41 Editor: Jen Beaumont. Office for National Statistics David Sweet Edition No: Social Trends 41 Editor: Jen Beaumont Office for National Statistics Social Trends 41 ISSN 2040 1620 A National Statistics publication National Statistics are produced to high professional

More information

Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008

Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 Investigating Community Cancer Concerns--Deer Park Community Advisory Council, 2008 David R. Risser, M.P.H., Ph.D. David.Risser@dshs.state.tx.us Epidemiologist Cancer Epidemiology and Surveillance Branch

More information

JSNA Factsheet Template Tower Hamlets Joint Strategic Needs Assessment 2010 2011

JSNA Factsheet Template Tower Hamlets Joint Strategic Needs Assessment 2010 2011 JSNA Factsheet Template Tower Hamlets Joint Strategic Needs Assessment 2010 2011. Executive Summary This fact sheet considers breast cancer, with a particular emphasis on breast screening and raising awareness

More information

CANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA. MCSS Epidemiology Report 99:2. September 1999

CANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA. MCSS Epidemiology Report 99:2. September 1999 CANCER INCIDENCE RATES IN NORTHEASTERN MINNESOTA MCSS Epidemiology Report 99: September 999 Minnesota Cancer Surveillance System Chronic Disease And Environmental Epidemiology Section Minnesota Department

More information

Table of Contents. I. Executive Summary... 1. A. Summary of our Findings... 1. II. Background... 2. III. Methodology... 4. IV. Key Data Sources...

Table of Contents. I. Executive Summary... 1. A. Summary of our Findings... 1. II. Background... 2. III. Methodology... 4. IV. Key Data Sources... Table of Contents I. Executive Summary... 1 A. Summary of our Findings... 1 II. Background... 2 III. Methodology... 4 IV. Key Data Sources... 6 A. WCIS Data... 6 B. SEER Data... 8 V. Discussion of NIOSH

More information

C a nc e r C e nter. Annual Registry Report

C a nc e r C e nter. Annual Registry Report C a nc e r C e nter Annual Registry Report 214 214 Cancer Registry Report Larraine A. Tooker, CTR Please note that the 214 Cancer Registry Annual Report is created in 214, but it reflects data on cases

More information

BRAIN TUMOUR RESEARCH FUNDING FLOWS

BRAIN TUMOUR RESEARCH FUNDING FLOWS BRAIN TUMOUR RESEARCH FUNDING FLOWS Ellen Harries, Iona Joy v London, April 2013 (updated) CONTENTS 1 Research brief and headline findings 2 Research funding for cancer 3 Brain tumour funding compared

More information

Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma 1960-2003

Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma 1960-2003 Cancer in Western Australia: Incidence and mortality 2003 and Mesothelioma 1960-2003 A report of the Western Australian Cancer Registry Health Data Collections, Information Collection and Management Department

More information

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers

Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Cancer in Northeastern Pennsylvania: Incidence and Mortality of Common Cancers Samuel M. Lesko, MD, MPH Medical Director Karen Ryczak, RN Surveillance Coordinator November 2015 334 Jefferson Avenue, Scranton,

More information

BETTER CANCER CARE, AN ACTION PLAN

BETTER CANCER CARE, AN ACTION PLAN , AN ACTION PLAN , AN ACTION PLAN The Scottish Government, Edinburgh 2008 Crown copyright 2008 ISBN: 978-0-7559-5857-3 The Scottish Government St Andrew s House Edinburgh EH1 3DG Produced for the Scottish

More information

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012

Cancer incidence and mortality patterns in Europe: Estimates for 40 countries in 2012 an Journal of Cancer (2013) 49, 1374 1403 Available at www.sciencedirect.com journalhomepage:www.ejcancer.info Cancer incidence and mortality patterns in : Estimates for 40 countries in 2012 J. Ferlay

More information

Do I really need critical illness cover? A guide to protect against the financial impact of a critical illness

Do I really need critical illness cover? A guide to protect against the financial impact of a critical illness Do I really need critical illness cover? A guide to protect against the financial impact of a critical illness What's inside 2 Cancer survival rates 5 Survival rates are improving 6 Coping with a critical

More information

2.5m. THe Rich PiCtuRE. 340,000 getting cancer for the first time. Living with cancer. 163,000 dying from cancer 94,000. Around.

2.5m. THe Rich PiCtuRE. 340,000 getting cancer for the first time. Living with cancer. 163,000 dying from cancer 94,000. Around. THe Rich PiCtuRE Other cancers 1,100,000 Around 340,000 getting cancer for the first time Lung 72,000 Colorectal 290,000 Breast 691,000 Prostate 330,000 2.5m Living with cancer 66% aged 65+ Around 163,000

More information

The Burden of Cancer in Asia

The Burden of Cancer in Asia P F I Z E R F A C T S The Burden of Cancer in Asia Medical Division PG283663 2008 Pfizer Inc. All rights reserved. Printed in USA/December 2008 In 2002, 4.2 million new cancer cases 39% of new cases worldwide

More information

Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University

Hospital-Based Tumor Registry. Srinagarind Hospital, Khon Kaen University Hospital-Based Tumor Registry Srinagarind Hospital, Khon Kaen University Statistical Report 2012 Cancer Unit, Faculty of Medicine Khon Kaen University Khon Kaen, Thailand Tel & Fax:+66(43)-202485 E-mail:

More information

inflammation of the pancreas and damage to the an increased risk of hypertension, stroke and Table 7.1: Classification of alcohol consumption

inflammation of the pancreas and damage to the an increased risk of hypertension, stroke and Table 7.1: Classification of alcohol consumption H E A LT H SURVEY Alcohol Consumption 7 Alcohol Consumption N AT I O N A L Introduction Excessive alcohol consumption is associated with inflammation of the pancreas and damage to the an increased risk

More information

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health

Ovarian Cancer. in Georgia, 1999-2003. Georgia Department of Human Resources Division of Public Health Ovarian Cancer in Georgia, 1999-23 Georgia Department of Human Resources Division of Public Health Acknowledgments Georgia Department of Human Resources......B. J. Walker, Commissioner Division of Public

More information

52,929,390 paid out in critical illness claims in the first six months of 2013*

52,929,390 paid out in critical illness claims in the first six months of 2013* Critical Illness Report (January to June 2013) 52,929,390 paid out in critical illness claims in the first six months of 2013* 66 % Cancer 12 % Heart Attack 9 % Other 3 % Benign Brain Tumour 4 % Multiple

More information

The Ontario Cancer Registry moves to the 21 st Century

The Ontario Cancer Registry moves to the 21 st Century The Ontario Cancer Registry moves to the 21 st Century Rebuilding the OCR Public Health Ontario Grand Rounds Oct. 14, 2014 Diane Nishri, MSc Mary Jane King, MPH, CTR Outline 1. What is the Ontario Cancer

More information

Total Cost of Cancer Care by Site of Service: Physician Office vs Outpatient Hospital

Total Cost of Cancer Care by Site of Service: Physician Office vs Outpatient Hospital Total Cost of Cancer Care by Site of Service: Physician Office vs Outpatient Hospital Prepared by Avalere Health, LLC Page 2 Executive Summary Avalere Health analyzed three years of commercial health plan

More information

Fewer people with coronary heart disease are being diagnosed as compared to the expected figures.

Fewer people with coronary heart disease are being diagnosed as compared to the expected figures. JSNA Coronary heart disease 1) Key points 2) Introduction 3) National picture 4) Local picture of CHD prevalence 5) Mortality from coronary heart disease in Suffolk County 6) Trends in mortality rates

More information

Butler Memorial Hospital Community Health Needs Assessment 2013

Butler Memorial Hospital Community Health Needs Assessment 2013 Butler Memorial Hospital Community Health Needs Assessment 2013 Butler County best represents the community that Butler Memorial Hospital serves. Butler Memorial Hospital (BMH) has conducted community

More information

Burden of Cancer Mississippi. Mississippi State Department of Health

Burden of Cancer Mississippi. Mississippi State Department of Health Burden of Cancer State Department of Health Cancer in : An Overview What is Cancer? Cancer is a large group of diseases characterized by uncontrolled growth and spread of abnormal cells. If the spread

More information

Chapter 15 Multiple myeloma

Chapter 15 Multiple myeloma Chapter 15 Multiple myeloma Peter Adamson Summary In the UK and in the 199s, multiple myeloma accounted for around 1 in 8 diagnosed cases of cancer and 1 in 7 deaths from cancer. There was relatively little

More information

Public Health Annual Report Statistical Compendium

Public Health Annual Report Statistical Compendium Knowsley Public Health Annual Report Statistical Compendium 2014/15 READER INFORMATION Title Department Author Reviewers Contributors Date of Release June 2015 'Knowsley Public Health Annual Report: Statistical

More information

Health Status. Health. Higher social groups report best health

Health Status. Health. Higher social groups report best health Focus on Health paints a picture of the health of people living in Britain. It includes information on broad measures of health, mortality, risk factors, some preventive measures and service provision.

More information

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing

Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing Defending the Rest Basics on Lung Cancer, Other Cancers and Asbestosis: Review of the B-Read and Pulmonary Function Testing OTHER CANCERS November 2013 Bruce T. Bishop Nancy E. Leary Willcox & Savage 440

More information

Description Code Recommendation Description Code. All natural death 001-799 IPH All natural death A00-R99

Description Code Recommendation Description Code. All natural death 001-799 IPH All natural death A00-R99 Natural death Description Code Recommendation Description Code All natural death 001-799 IPH All natural death A00-R99 Infectious and parasitic diseases 001-139 CDC, EUROSTAT, CBS & VG Infectious and parasitic

More information

Are you worried about prostate cancer? 1

Are you worried about prostate cancer? 1 Are you worried about prostate cancer? 1 Are you worried about prostate cancer? This information is from the leaflet Are you worried about prostate cancer? You may find the full leaflet helpful. We can

More information

Prostate cancer statistics

Prostate cancer statistics Prostate cancer in Australia The following material has been sourced from the Australian Institute of Health and Welfare Prostate cancer incorporates ICD-10 cancer code C61 (Malignant neoplasm of prostate).

More information

Likelihood of Cancer

Likelihood of Cancer Suggested Grade Levels: 9 and up Likelihood of Cancer Possible Subject Area(s): Social Studies, Health, and Science Math Skills: reading and interpreting pie charts; calculating and understanding percentages

More information

Southern NSW Local Health District: Our Population s Health

Southern NSW Local Health District: Our Population s Health Page 1 of 5 This Factsheet summarises a selection of health indicators (health behaviours & risk factors, hospitalisations and deaths) for the of the Southern NSW Local Health District (LHD). Health services

More information

Mužík J., Dušek L., Blaha M., Klika P. Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech republic

Mužík J., Dušek L., Blaha M., Klika P. Institute of Biostatistics and Analyses, Masaryk University, Brno, Czech republic Hospital-based data in regional and local strategies optimizing CRC control and management: real-world outcomes of the Czech National Cancer Control Programme Mužík J., Dušek L., Blaha M., Klika P. Institute

More information

The Price of Cancer The public price of registered cancer in New Zealand

The Price of Cancer The public price of registered cancer in New Zealand The Price of Cancer The public price of registered cancer in New Zealand Citation: The Price of Cancer: The public price of registered cancer in New Zealand. Wellington: Ministry of Health. Published in

More information

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center

co-sponsored by the Health & Physical Education Department, the Health Services Office, and the Student Development Center Cancer is a group of more than 100 related diseases. Normally, cells grow and divide to produce more cells to keep the body healthy. Sometimes, this process goes wrong. New cells form when the body doesn

More information

Canadian Cancer Statistics

Canadian Cancer Statistics Canadian Cancer Statistics 2010 Special Topic: End-of-Life Care www.cancer.ca PRODUCED BY: CANADIAN CANCER SOCIETY, STATISTICS CANADA, PROVINCIAL/ TERRITORIAL CANCER REGISTRIES, PUBLIC HEALTH AGENCY OF

More information

in Australia an overview 2012

in Australia an overview 2012 Cancer in Australia an overview 212 Cancer in Australia: an overview, 212 presents the latest available information on incidence, mortality, survival, prevalence, burden of cancer, hospitalisations and

More information

43,303,919 paid out in critical illness claims in the first six months of 2012*

43,303,919 paid out in critical illness claims in the first six months of 2012* Critical Illness Claims Report 43,303,919 out in critical illness claims in the first six months of 2012* 60 % Cancer 16 % Heart Attack 10 % Other 3 % Benign Brain Tumour 5 % Multiple Sclerosis 6 % Stroke

More information

Cancer in Norway 2008

Cancer in Norway 2008 Cancer in Norway 8 Cancer incidence, mortality, survival and prevalence in Norway Special issue: The Janus Serum Bank From sample collection to cancer research Cancer in Norway 8 Editor-in-chief: Freddie

More information

Cancer Facts & Figures for African Americans 2013-2014

Cancer Facts & Figures for African Americans 2013-2014 Cancer Facts & Figures for African Americans 213-214 Contents Cancer Statistics 1 Selected Cancers 1 Cancer Prevention & Early Detection 14 Screening Guidelines for the Early Detection of Cancer in Average-risk

More information

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014

Estimated New Cases of Leukemia, Lymphoma, Myeloma 2014 ABOUT BLOOD CANCERS Leukemia, Hodgkin lymphoma (HL), non-hodgkin lymphoma (NHL), myeloma, myelodysplastic syndromes (MDS) and myeloproliferative neoplasms (MPNs) are types of cancer that can affect the

More information

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President

JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Breast Cancer Epidemiology i in China JESSE HUANG ( 黄 建 始 ),MD,MHPE,MPH,MBA Professor of Epidemiology Assistant President Chinese Academy of Medical Sciences Peking Union Medical College Medical Center

More information

Munich Cancer Registry

Munich Cancer Registry Munich Cancer Registry Survival Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, 81377 Germany http://www.tumorregister-muenchen.de/en Cancer

More information

Death Data: CDC Wonder, Texas Health Data, and VitalWeb

Death Data: CDC Wonder, Texas Health Data, and VitalWeb Death Data: CDC Wonder, Texas Health Data, and VitalWeb Evidence-Based Public Health Practice Step 2: Quantify the Issue This handout demonstrates how to access CDC Wonder, Texas Health Data, and VitalWeb

More information

What is cancer? Teacher notes. Key stage 4/4 TH LEVEL Science lesson plan with links to PSHE

What is cancer? Teacher notes. Key stage 4/4 TH LEVEL Science lesson plan with links to PSHE What is cancer? Teacher notes Key stage 4/4 TH LEVEL Science lesson plan with links to PSHE Overview Subjects England: Science (with links to PSHE) Wales: Science (with links to PSE) Scotland: Sciences

More information

Cancer Survival in New Jersey 1979-2005

Cancer Survival in New Jersey 1979-2005 Cancer Survival in New Jersey 1979-2005 Cancer Epidemiology Services Public Health Services Branch New Jersey Department of Health Chris Chris e, Governor Kim Guadagno, Lt. Governor Mary E. O Dowd, MPH

More information

DELRAY MEDICAL CENTER. Cancer Program Annual Report

DELRAY MEDICAL CENTER. Cancer Program Annual Report DELRAY MEDICAL CENTER Cancer Program Annual Report Cancer Statistical Data From 2010 TABLE OF CONTENTS Chairman s Report....3 Tumor Registry Statistical Report Summary...4-11 Lung Study.12-17 Definitions

More information

Mutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base

Mutations: 2 general ways to alter DNA. Mutations. What is a mutation? Mutations are rare. Changes in a single DNA base. Change a single DNA base Mutations Mutations: 2 general ways to alter DNA Change a single DNA base Or entire sections of DNA can move from one place to another What is a mutation? Any change in the nucleotide sequence of DNA Here

More information

Munich Cancer Registry

Munich Cancer Registry Munich Cancer Registry Survival Selection Matrix Homepage Deutsch Munich Cancer Registry at Munich Cancer Center Marchioninistr. 15 Munich, 81377 Germany http://www.tumorregister-muenchen.de/en Cancer

More information

Lung Cancer: More than meets the eye

Lung Cancer: More than meets the eye Lung Cancer Education Program November 23, 2013 Lung Cancer: More than meets the eye Shantanu Banerji MD, FRCPC Presenter Disclosure Faculty: Shantanu Banerji Relationships with commercial interests: Grants/Research

More information

Final Report Australian Firefighters Health Study. Summary

Final Report Australian Firefighters Health Study. Summary Final Report Australian Firefighters Health Study Summary School of Public Health & Preventive Medicine Faculty of Medicine, Nursing and Health Sciences December 2014 STUDY TEAM Monash University Principal

More information

Cancer Screening and Early Detection Guidelines

Cancer Screening and Early Detection Guidelines Cancer Screening and Early Detection Guidelines Guillermo Tortolero Luna, MD, PhD Director Cancer Control and Population Sciences Program University of Puerto Rico Comprehensive Cancer Center ASPPR Clinical

More information

Selected Health Status Indicators DALLAS COUNTY. Jointly produced to assist those seeking to improve health care in rural Alabama

Selected Health Status Indicators DALLAS COUNTY. Jointly produced to assist those seeking to improve health care in rural Alabama Selected Health Status Indicators DALLAS COUNTY Jointly produced to assist those seeking to improve health care in rural Alabama By The Office of Primary Care and Rural Health, Alabama Department of Public

More information

Canadian Cancer Statistics

Canadian Cancer Statistics Canadian Cancer Statistics 2008 www.cancer.ca PRODUCED BY: CANADIAN CANCER SOCIETY, NATIONAL CANCER INSTITUTE OF CANADA, STATISTICS CANADA, PROVINCIAL/ TERRITORIAL CANCER REGISTRIES, PUBLIC HEALTH AGENCY

More information

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006

Table 16a Multiple Myeloma Average Annual Number of Cancer Cases and Age-Adjusted Incidence Rates* for 2002-2006 Multiple Myeloma Figure 16 Definition: Multiple myeloma forms in plasma cells that are normally found in the bone marrow. 1 The plasma cells grow out of control and form tumors (plasmacytoma) or crowd

More information

Summary of Investigation into the Occurrence of Cancer Census Tract 2104 Zip Code 77009, Houston Harris County, Texas 1998 2007 May 11, 2010

Summary of Investigation into the Occurrence of Cancer Census Tract 2104 Zip Code 77009, Houston Harris County, Texas 1998 2007 May 11, 2010 Summary of Investigation into the Occurrence of Cancer Census Tract 2104 Zip Code 77009, Houston Harris County, Texas 1998 2007 May 11, 2010 Background: Concern about a possible excess of cancer prompted

More information

Frequently Asked Questions About Ovarian Cancer

Frequently Asked Questions About Ovarian Cancer Media Contact: Gerri Gomez Howard Cell: 303-748-3933 gerri@gomezhowardgroup.com Frequently Asked Questions About Ovarian Cancer What is ovarian cancer? Ovarian cancer is a cancer that forms in tissues

More information

)HDWXULQJ &RORUHFWDO &DQFHU

)HDWXULQJ &RORUHFWDO &DQFHU CANADIAN STATISTICS Members of the Steering Committee on Cancer Statistics Heather Chappell (Chair), MSc, CHE Cancer Control Policy, Canadian Cancer Society, Toronto, Ontario Prithwish De, PhD Cancer Control

More information

Community Health Assessment 2012

Community Health Assessment 2012 Community Health Assessment 2012 Licking County Health Department 675 Price Road Newark, Ohio 43055 www.lickingcohealth.org Assessment Commissioned By: R. Joseph Ebel, RS, MS, MBA Health Commissioner Assessment

More information

How To Calculate Cancer Deaths And Incidence For 2000-2004

How To Calculate Cancer Deaths And Incidence For 2000-2004 sdasda Prepared by Paul K. Mills, Ph.D., M.P.H Richard C. Yang, M.P.H Jennifer L. Dodge, M.P.H Public Health Institute Cancer Registry of Central California 1320 E. Shaw Ave., Suite 160 Fresno, CA 93710

More information

Critical illness cover. It s about time.

Critical illness cover. It s about time. Report prepared for 9 December 2015 Critical illness cover. It s about time. Term-based life cover s simple. You die within the term, it pays out. You don t, it doesn t. Unfortunately, life itself isn

More information

Health Summary NHS East and North Hertfordshire Clinical Commissioning Group January 2013

Health Summary NHS East and North Hertfordshire Clinical Commissioning Group January 2013 Appendix A Health Summary NHS East and North Clinical Commissioning Group January 213 NHS East and North CCG Royston area has been shaded North East The five constituent districts of NHS East and North

More information

Pancreatic Cancer Research Funding: Too little for too long.

Pancreatic Cancer Research Funding: Too little for too long. Pancreatic Cancer Research Funding: Too little for too long. A report by Pancreatic Cancer Action. Introduction Pancreatic cancer is the UK s fifth biggest cancer killer i, which accounted for 8320 deaths

More information

Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada.

Cancer is the leading cause of death for Canadians aged 35 to 64 and is also the leading cause of critical illness claims in Canada. Underwriting cancer In this issue of the Decision, we provide an overview of Canadian cancer statistics and the information we use to make an underwriting decision. The next few issues will deal with specific

More information

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group

Scottish Diabetes Survey 2013. Scottish Diabetes Survey Monitoring Group Scottish Diabetes Survey 2013 Scottish Diabetes Survey Monitoring Group Contents Contents... 2 Foreword... 4 Executive Summary... 6 Prevalence... 8 Undiagnosed diabetes... 18 Duration of Diabetes... 18

More information

Chapter 1. Burden: mortality, morbidity and risk factors

Chapter 1. Burden: mortality, morbidity and risk factors Chapter 1 Burden: mortality, morbidity and risk factors This chapter reviews the current burden and trends of NCDs and the risk factors. It also provides the latest estimates on the number, rates and causes

More information

Alabama Cancer Facts & Figures 2011

Alabama Cancer Facts & Figures 2011 Alabama Cancer Facts & Figures 2011 1.800.227.2345 cancer.org Have questions about cancer? Cancer information specialists are available 24 hours a day, 7 days a week. Call the American Cancer Society at

More information

The role of cancer registries

The role of cancer registries The role of cancer registries 17.1 Aims of cancer registries The cancer registry is an organization for the systematic collection, storage, analysis, interpretation and reporting of data on subjects with

More information

Mortality from Prostate Cancer Urological Cancers SSCRG

Mortality from Prostate Cancer Urological Cancers SSCRG 1 Mortality from Prostate Cancer Urological Cancers SSCRG Headline Findings Over 10,000 men die from prostate cancer in the UK each year, nearly 9,000 in England. The rate of death from prostate cancer

More information

Cancer Statistics, 2013

Cancer Statistics, 2013 CA CANCER J CLIN 2013;63:11 30 Cancer Statistics, 2013 Rebecca Siegel, MPH 1 ; Deepa Naishadham, MA, MS 2 ; Ahmedin Jemal, DVM, PhD 3 Each year, the American Cancer Society estimates the numbers of new

More information

Prostate Cancer in the West Midlands

Prostate Cancer in the West Midlands West Midlands Cancer Intelligence Unit Prostate Cancer in the West Midlands k Supporting the fight against cancer through timely, high quality information provision Report Number R12/4 October 212 Author:

More information

Protecting and improving the nation s health. Alcohol treatment in England 2013-14

Protecting and improving the nation s health. Alcohol treatment in England 2013-14 Protecting and improving the nation s health Alcohol treatment in England 2013-14 October 2014 About Public Health England Public Health England exists to protect and improve the nation s health and wellbeing,

More information

MONSANTO COMPANY (ama SOLUTIA INCORPORATED) ANNISTON, CALHOUN COUNTY, ALABAMA FEBRUARY 14,2000

MONSANTO COMPANY (ama SOLUTIA INCORPORATED) ANNISTON, CALHOUN COUNTY, ALABAMA FEBRUARY 14,2000 ........-. Health Consultation Public Comment Release Evaluation of Soil, Blood '& Air Data from Anniston, Alabama ' MONSANTO COMPANY (ama SOLUTIA INCORPORATED) ANNISTON, CALHOUN COUNTY, ALABAMA CERCLIS

More information

Critical Illness with Term Assurance

Critical Illness with Term Assurance AIG Life Critical Illness with Term Assurance Our comprehensive Critical Illness with Term Assurance delivers more value and quality to the customer and their family than ever before. It is designed to

More information

Breast cancer: diagnosis and treatment

Breast cancer: diagnosis and treatment Breast cancer: diagnosis and treatment An assessment of need A report to the National Collaborating Centre for Cancer Dr Robyn Dewis, Derby City Primary Care Trust Jonathan Gribbin, Derbyshire County Primary

More information

DESIGN YOUR OWN HEALTH CAMPAIGN LESSON PLAN

DESIGN YOUR OWN HEALTH CAMPAIGN LESSON PLAN DESIGN YOUR OWN HEALTH CAMPAIGN LESSON PLAN OVERVIEW 3 CURRICULUM LINKS AND AIMS 4 BACKGROUND INFORMATION FOR TEACHERS 5 ACTIVITIES 7 STUDENT FACTSHEETS 9 CAMPAIGN COSTS 13 OVERVIEW The government and

More information

Statistical Report on Health

Statistical Report on Health Statistical Report on Health Part II Mortality Status (1996~24) Table of Contents Table of Contents...2 List of Tables...4 List of Figures...5 List of Abbreviations...6 List of Abbreviations...6 Introduction...7

More information

Breast Cancer in the Family

Breast Cancer in the Family Oxford University Hospitals NHS Trust Oxford Regional Genetic Department Breast Cancer in the Family Information for women with a moderately increased risk of breast cancer Breast cancer in the family

More information

Alcohol, Drugs and Tobacco in Lancashire Section 1: Alcohol. November 2012. Intelligence for Healthy Lancashire (JSNA) NEE

Alcohol, Drugs and Tobacco in Lancashire Section 1: Alcohol. November 2012. Intelligence for Healthy Lancashire (JSNA) NEE Alcohol, Drugs and Tobacco in Lancashire Section 1: Alcohol November 2012 Intelligence for Healthy Lancashire (JSNA) NEE Contents CONTENTS... 2 ALCOHOL CONSUMPTION... 4 DEMOGRAPHICS... 5 Ethnicity... 5

More information

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON*

PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* PATTERNS OF MORTALITY IN ASBESTOS FACTORY WORKERS IN LONDON* M. L. Newhouse TUC Centenary Institute of Occupational Health London School of Hygiene and Tropical Medicine London WCIE 7HT. England G. Berry

More information

Indices of Morbidity and Mortality. Sukon Kanchanaraksa, PhD Johns Hopkins University

Indices of Morbidity and Mortality. Sukon Kanchanaraksa, PhD Johns Hopkins University This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike License. Your use of this material constitutes acceptance of that license and the conditions of use of materials on this

More information

The third all breast cancer report

The third all breast cancer report The third all breast cancer report Back to basics: Breast cancer incidence and mortality West Midlands Knowledge and Intelligence Team, Public Health England and the National Cancer Intelligence Network

More information

Work-Related Disease in New Zealand

Work-Related Disease in New Zealand LABOUR AND COMMERCIAL ENVIRONMENT Work-Related Disease in New Zealand The state of play in 2010 MB 12548 AUG 13 Ministry of Business, Innovation and Employment (MBIE) Hīkina Whakatutuki Lifting to make

More information

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia?

La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia? La sopravvivenza dei tumori maligni nei confronti internazionali: anticipazione della diagnosi o modifica del decorso naturale della malattia? Paola Pisani Registro Tumori Infantili Piemonte Università

More information